Search clinical trials for: XL647
Total 21 results
-
ExelixisWithdrawnCancer | Breast Cancer | Non-small-cell Lung CancerUnited States
-
Kadmon Corporation, LLCCompletedGlioblastoma | Brain Tumor | Recurrent GlioblastomaUnited States
-
Kadmon, a Sanofi CompanyCompletedPolycystic Kidney, Autosomal DominantUnited States
-
SanofiCompletedEndometrial Neoplasms | Endometrial CancerUnited States, Belgium
-
SanofiCompletedLymphoma | CancerUnited States, Spain
-
Kadmon Corporation, LLCCompletedNon-Small Cell Lung Cancer | Brain Metastases | Leptomeningeal MetastasesUnited States
-
SanofiCompletedSolid TumorsUnited States
-
SanofiCompletedGlioblastoma | Astrocytoma, Grade IVUnited States
-
Kadmon Corporation, LLCCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Kadmon Corporation, LLCCompleted
-
Kadmon Corporation, LLCCompleted
-
Kadmon Corporation, LLCCompletedPolycystic Kidney, Autosomal RecessiveUnited States
-
Kadmon Corporation, LLCCompleted
-
Kadmon Corporation, LLCTerminatedAutosomal Dominant Polycystic Kidney Disease (ADPKD)United States
-
Kadmon Corporation, LLCTerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Kadmon, a Sanofi CompanyCompletedAutosomal Dominant Polycystic Kidney | ADPKDUnited States
-
Kadmon Corporation, LLCTerminatedHER-2 Positive Breast Cancer | Metastatic Malignant Neoplasm to BrainUnited States
-
SanofiCompletedCancer | Non-small Cell Lung CancerUnited States
-
SanofiCompletedCancer | Non-Small Cell Lung Cancer | Endometrial Carcinoma | Ovarian CarcinomaUnited States
-
SanofiCompletedBreast Cancer | Breast NeoplasmsUnited States, Spain
-
SanofiCompletedBreast CancerUnited States, France, Spain